3,319 Shares in The Cigna Group (NYSE:CI) Purchased by Wynn Capital LLC

Wynn Capital LLC bought a new stake in shares of The Cigna Group (NYSE:CI) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 3,319 shares of the health services provider’s stock, valued at approximately $994,000.

A number of other institutional investors and hedge funds have also made changes to their positions in CI. Bogart Wealth LLC increased its stake in shares of The Cigna Group by 104.5% during the third quarter. Bogart Wealth LLC now owns 90 shares of the health services provider’s stock valued at $26,000 after purchasing an additional 46 shares in the last quarter. OFI Invest Asset Management purchased a new stake in shares of The Cigna Group during the third quarter valued at approximately $26,000. Fortitude Family Office LLC purchased a new stake in shares of The Cigna Group during the fourth quarter valued at approximately $29,000. VisionPoint Advisory Group LLC grew its holdings in shares of The Cigna Group by 112.2% during the third quarter. VisionPoint Advisory Group LLC now owns 104 shares of the health services provider’s stock valued at $30,000 after buying an additional 55 shares during the last quarter. Finally, Pacifica Partners Inc. grew its holdings in shares of The Cigna Group by 73.2% during the fourth quarter. Pacifica Partners Inc. now owns 142 shares of the health services provider’s stock valued at $43,000 after buying an additional 60 shares during the last quarter. Institutional investors own 86.99% of the company’s stock.

Insider Buying and Selling at The Cigna Group

In other The Cigna Group news, CEO David Cordani sold 38,065 shares of The Cigna Group stock in a transaction on Friday, February 9th. The shares were sold at an average price of $335.22, for a total value of $12,760,149.30. Following the sale, the chief executive officer now directly owns 329,321 shares in the company, valued at approximately $110,394,985.62. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other The Cigna Group news, CEO David Cordani sold 38,065 shares of The Cigna Group stock in a transaction on Friday, February 9th. The shares were sold at an average price of $335.22, for a total value of $12,760,149.30. Following the completion of the transaction, the chief executive officer now directly owns 329,321 shares of the company’s stock, valued at approximately $110,394,985.62. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Eric P. Palmer sold 6,083 shares of The Cigna Group stock in a transaction on Tuesday, February 13th. The stock was sold at an average price of $340.00, for a total transaction of $2,068,220.00. Following the completion of the transaction, the insider now directly owns 44,649 shares of the company’s stock, valued at $15,180,660. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 114,144 shares of company stock worth $39,296,330. Insiders own 0.70% of the company’s stock.

The Cigna Group Price Performance

Shares of CI stock traded down $0.38 on Wednesday, hitting $352.27. 1,120,784 shares of the stock traded hands, compared to its average volume of 1,588,393. The firm has a market cap of $102.99 billion, a price-to-earnings ratio of 20.26, a PEG ratio of 1.08 and a beta of 0.56. The Cigna Group has a 52 week low of $240.50 and a 52 week high of $365.71. The firm has a 50 day simple moving average of $349.03 and a two-hundred day simple moving average of $316.84. The company has a debt-to-equity ratio of 0.61, a current ratio of 0.67 and a quick ratio of 0.67.

The Cigna Group (NYSE:CI) last announced its quarterly earnings data on Friday, February 2nd. The health services provider reported $6.79 EPS for the quarter, beating the consensus estimate of $6.54 by $0.25. The firm had revenue of $51.15 billion for the quarter, compared to the consensus estimate of $48.91 billion. The Cigna Group had a net margin of 2.64% and a return on equity of 13.59%. The company’s revenue was up 11.8% on a year-over-year basis. During the same period last year, the firm earned $4.96 EPS. As a group, equities research analysts predict that The Cigna Group will post 28.36 earnings per share for the current fiscal year.

The Cigna Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 20th. Shareholders of record on Tuesday, June 4th will be issued a $1.40 dividend. This represents a $5.60 dividend on an annualized basis and a yield of 1.59%. The Cigna Group’s dividend payout ratio is currently 32.20%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on CI shares. Sanford C. Bernstein upgraded shares of The Cigna Group from a “market perform” rating to an “outperform” rating and increased their price target for the company from $330.00 to $372.00 in a report on Thursday, January 4th. Wells Fargo & Company raised their target price on shares of The Cigna Group from $334.00 to $348.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 6th. Royal Bank of Canada upgraded shares of The Cigna Group from a “sector perform” rating to an “outperform” rating and raised their target price for the stock from $327.00 to $354.00 in a report on Monday, February 5th. Deutsche Bank Aktiengesellschaft upgraded shares of The Cigna Group from a “hold” rating to a “buy” rating and raised their target price for the stock from $355.00 to $370.00 in a report on Thursday, February 1st. Finally, Morgan Stanley restated an “overweight” rating and issued a $392.00 target price (up previously from $382.00) on shares of The Cigna Group in a report on Monday, March 4th. Two research analysts have rated the stock with a hold rating, ten have given a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, The Cigna Group currently has a consensus rating of “Buy” and a consensus price target of $362.14.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.